The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis

Area of Science:

• Cardiology
• Pathophysiology
• Biochemistry

Background:

• Heart disease and metabolic disorders cause atrial cardiomyopathy, characterized by structural and functional myocardial changes.
• Fibrosis, hypertrophy, and fatty infiltration in the atria contribute to atrial fibrillation (AF) vulnerability.
• Atrial cardiomyopathy is linked to thromboembolic events, notably stroke.

Purpose of the Study:

• To review mechanisms linking atrial cardiomyopathy to thrombogenesis.
• To explore the impact of activated coagulation factors on atrial remodeling.
• To elucidate the complex relationship between AF, stroke, and atrial cardiomyopathy.

Main Methods:

• Review of existing literature on atrial cardiomyopathy, AF, and stroke.
• Analysis of pathological mechanisms in animal models.
• Examination of the role of coagulation factors in atrial remodeling.

Main Results:

• Atrial cardiomyopathy promotes thrombotic events in the atria and interstitium.
• Activated coagulation factors exert pleiotropic effects, exacerbating atrial cardiomyopathy.
• A multidirectional causal relationship exists between atrial cardiomyopathy, hypercoagulability, and stroke.

Conclusions:

• Atrial cardiomyopathy is a key driver of thrombogenesis, increasing stroke risk.
• Hypercoagulability and atrial remodeling create a vicious cycle.
• Understanding these interactions is crucial for managing AF and stroke risk.